Daiichi, Sankyo Deal Aimed At Fending Off Foreign Competition In Japan

The new company, Daiichi Sankyo, will be the second largest Japanese pharmaceutical company based on domestic sales. The top 10 Japanese pharma companies have lost 3% of market share in the last 13 years, while the top 10 foreign companies have gained significantly, Daiichi's CEO says.